Markus Meissner

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 8

Top Venues

Cancers

Cancer management and research

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Elias A T Koch, Anne Petzold, Anja Wessely, Edgar Dippel, Anja Gesierich, Ralf Gutzmer, Jessica C Hassel, Sebastian Haferkamp, Katharina C Kähler, Harald Knorr, Nicole Kreuzberg, Ulrike Leiter, Carmen Loquai, Friedegund Meier, Markus Meissner, Peter Mohr, Claudia Pföhler, Farnaz Rahimi, Dirk Schadendorf, Beatrice Schell, Max Schlaak, Patrick Terheyden, Kai-Martin Thoms, Beatrice Schuler-Thurner, Selma Ugurel, Jens Ulrich, Jochen Sven Utikal, Michael Weichenthal, Fabian Ziller, Carola Berking, Markus Vincent Heppt
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity. Cancers 14 (3) (2022)
Eleni Zoga, Robert Wolff, Hanns Ackermann, Markus Meissner, Claus Rödel, Nikolaos Tselis, Georgios Chatzikonstantinou
Factors Associated with Hemorrhage of Melanoma Brain Metastases after Stereotactic Radiosurgery in the Era of Targeted/Immune Checkpoint Inhibitor Therapies. Cancers 14 (10) (2022)
Johannes Kleemann, Katja Steinhorst, Veronika König, Nadja Nicole Zöller, Jindrich Cinatl, Deniz Özistanbullu, Roland Kaufmann, Markus Meissner, Stefan Kippenberger
Functional Downregulation of PD-L1 and PD-L2 by CpG and non-CpG Oligonucleotides in Melanoma Cells. Cancers 14 (19) (2022)
Raphael Wilhelm, Timon Eckes, Gergely Imre, Stefan Kippenberger, Markus Meissner, Dominique Thomas, Sandra Trautmann, Jean-Philippe Merlio, Edith Chevret, Roland Kaufmann, Josef Pfeilschifter, Alexander Koch, Manuel Jäger
C6 Ceramide (d18:1/6:0) as a Novel Treatment of Cutaneous T Cell Lymphoma. Cancers 13 (2) (2021)
Johannes Kleemann, Manuel Jäger, Eva Valesky, Stefan Kippenberger, Roland Kaufmann, Markus Meissner
Real-World Experience of Talimogene Laherparepvec (T-VEC) in Old and Oldest-Old Patients with Melanoma: A Retrospective Single Center Study. Cancer management and research 13 (2021)
Elias A T Koch, Anne Petzold, Anja Wessely, Edgar Dippel, Anja Gesierich, Ralf Gutzmer, Jessica C Hassel, Sebastian Haferkamp, Bettina Hohberger, Katharina C Kähler, Harald Knorr, Nicole Kreuzberg, Ulrike Leiter, Carmen Loquai, Friedegund Meier, Markus Meissner, Peter Mohr, Claudia Pföhler, Farnaz Rahimi, Dirk Schadendorf, Beatrice Schell, Max Schlaak, Patrick Terheyden, Kai-Martin Thoms, Beatrice Schuler-Thurner, Selma Ugurel, Jens Ulrich, Jochen Sven Utikal, Michael Weichenthal, Fabian Ziller, Carola Berking, Markus Vincent Heppt, null On Behalf Of The German Dermatologic Cooperative Oncology Group DeCOG Committee Ocular Melanoma
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis. Cancers 13 (13) (2021)
Johannes Kleemann, Gabi Reichenbach, Nadja Zöller, Manuel Jäger, Roland Kaufmann, Markus Meissner, Stefan Kippenberger
Heavy Water Affects Vital Parameters of Human Melanoma Cells in vitro. Cancer management and research 12 (2020)
Moritz Möller, Julia Wasel, Julia Schmetzer, Ulrike Weiß, Markus Meissner, Susanne Schiffmann, Andreas Weigert, Christine V Möser, Ellen Niederberger
The Specific IKKε/TBK1 Inhibitor Amlexanox Suppresses Human Melanoma by the Inhibition of Autophagy, NF-κB and MAP Kinase Pathways. International journal of molecular sciences 21 (13) (2020)

Markus Meissner.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Markus Meissner